The lipooligosaccharide (LOS) of a Neisseria meningitidis acetate auxotroph was metabolically labeled with either [2-13 C]-sodium acetate or [1,2-13 C 2 ]-sodium acetate. In this study, we demonstrated that this label was efficiently incorporated into both the lipid A acyl moieties and the two N-acetylglucosamines present in the oligosaccharide branch of the LOS. The development of this efficient labeling protocol should prove useful in future structural studies analyzing the interactions between LOS and host proteins.
INTRODUCTION
Neisseria meningitidis is the causative agent of endemic and epidemic meningococcal disease world-wide. Lipooligosaccharide (LOS; endotoxin) is the principal glycolipid present in the outer membrane of N. meningitidis. LOS is structurally related to lipopolysaccharide (LPS), but unlike LPS, LOS does not contain the repeating O-antigen. Instead, LOS consists of three domains: one or more oligosaccharide chains, the core region, and the lipid A. The structurally variable oligosaccharides that extend from the conserved core region have been shown to be involved in molecular mimicry. 1-3 N. meningitidis lipid A is highly conserved and is structurally similar to lipid A from other Gram-negative bacteria. [4] [5] [6] [7] [8] Lipid A anchors the LOS/LPS to the outer membrane and is responsible for activation of host cells by LOS. 4, 9, 10 LOS is a potent activator of cells of the innate immune system. LOS is capable of promoting the release of various cytokines 1, 11, 12 and interacting with a number of host components including: lipopolysaccharide-binding protein (LBP), CD14, and MD-2 needed for potent Toll-like receptor 4 (TLR4)-dependent cell activation. [13] [14] [15] [16] [17] [18] These factors are important for prompt mobilization of host defenses needed to eliminate invading bacteria. However, excessive LOS-induced inflammation can also play an important role in the progression of meningococcal infections. 19 A better understanding of LOS interactions with some of the host cell proteins could be facilitated through detailed structural characterization of these complexes. Therefore, the goal of this study was to develop some of the chemical tools necessary to allow further characterization of these LOS-host protein interactions. In this study, the LOS from a N. meningitidis acetate auxotroph was metabolically labeled with sodium [ 13 C]-acetate. Mass spectrometric analyses demonstrated that this label was efficiently incorporated in both the lipid A and oligosaccharide portions of the LOS.
MATERIALS AND METHODS

Bacterial growth and LOS labeling and purification conditions
In this study, an acetate auxotroph of N. meningitidis serogroup B (NMBACE1) 20 was utilized for metabolic labeling and purification of [ 13 C]-LOS. In brief, the bacteria were harvested from GC agar (Difco Laboratories, Inc., Detroit, MI, USA) supplemented with 1% (v/v) isovitalex and resuspended to a density of A 660 = 0.05 in 600 ml of Morse's defined medium (MDM) supplemented with 1% isovitalex, 10 mM sodium bicarbonate and one of the following: 2 mM sodium acetate (NMBACE1-12 C), 2 mM sodium [2-13 C]-acetate (NMBACE1-13 CEO), or 2 mM sodium [1,2-13 C 2 ]-acetate (NMBACE1-13 CE). Both forms of [ 13 C]-labeled sodium acetate were purchased from ICN Biochemicals (Cleveland, OH, USA). The bacteria were cultured at 37°C with shaking (180 rpm) to late log phase (A 660 = 0.8-1.0). The bacteria were harvested by centrifugation at 2000 g for 10 min, washed with 10 ml of MDM, twice, and the recovered bacterial pellet stored at -20°C until extraction. LOS was purified by a previously described modified hot phenol-water method. 20 The LOS pellet was dried at 37°C, resuspended in cold distilled water to an estimated concentration of 3 mg LOS/ml (about 2 mg LOS recovered per 100 ml of culture) and sonicated at room temperature for 15 min in a water bath sonicator. The LOS was re-sedimented by ultra-centrifugation at 150,000 g for 1.5 h, twice, and re-suspended in water at a concentration of ~3 mg LOS/ml. The purity of the sample was confirmed by SDS-PAGE, silver staining of the polyacrylamide gels, and fatty acid analysis. 3 
Preparation of lipid A and oligosaccharide (OS) fractions
Lipid A and OS fractions were prepared by acetic acid hydrolysis of the LOS as previously described. 21 Dephosphorylated OS samples were prepared by addition of 15 µl of 48% aqueous HF to each dried OS fraction at 4°C for 16 h. The HF was removed, with nitrogen gas, under vacuum.
Matrix-assisted-laser-desorption ionization time-offlight (MALDI-TOF) mass spectrometry analysis of lipid A samples
Lipid A samples were dissolved in CHCl 3 /CH 3 OH (3:1, v/v) and were mixed 1:1 (v/v) with a 5-chloro-2-mercaptobenzothiazole (CMBT) matrix solution (saturated solution of CMBT in CHCl 3 /CH 3 OH [3:1, v/v]). Mass spectra were acquired with a Voyager MALDI-TOF instrument (Applied Biosystems) run in the reflectron negative-ion mode under delayed extraction conditions with a 68% grid voltage, 250 ns delay time, and an acceleration voltage of 20,000 V. Samples were calibrated externally with a mixture consisting of angiotension I, and ACTH fragments 1-7, 18-39, and 7-38 (Bachem, Torrance, CA, USA). All masses measured under these conditions were mono-isotopic mass values.
Electrospray ionization mass spectrometry (ESI-MS) of OS fractions
ESI-MS and tandem mass spectra (ESI-MS/MS) of the OS fractions were recorded using static nanospray in the positive-ion mode, with a nanospray needle voltage of 1100 V, on a quadrupole orthogonal time-of-flight mass spectrometer (QSTAR Pulsar i, MDS Sciex, Concord, Canada) equipped with a Proxeon Biosystems (Odense, Denmark) nanospray ion source. OS samples with a starting concentration of ~1 µg/µl were diluted 1:25 in a 1:1 (v/v) solution of 100 mM NH 4 OAc (pH 5) and acetonitrile, and 2.5 µl of each analyte was deposited into a Proxeon nanospray tip. For collision-induced dissociation (CID) MS/MS, selected ions were fragmented in a collision cell, using nitrogen as the collision gas with collision energies of 20-30, and were analyzed in the orthogonal TOF. The mass window for the precursor ion selection of the quadrupole mass analyzer was generally set to ± 1 m/z. Spectra were externally calibrated using MS/MS fragment-ions of a renin peptide standard (His immonium-ion with m/z at 110.0713, and b 8 -ion with m/z at 1028.5312) providing a mass accuracy of ≤ 50 ppm. All masses detected by ESI-MS and ESI-MS/MS, as described above, were mono-isotopic mass values.
RESULTS AND DISCUSSION
The structure of the lipid A from N. meningitidis has been determined to consist of a di-glucosamine backbone symmetrically substituted with two lauric acid groups (C 12:0 ), two hydroxy-lauric acid groups (3-OH-C 12:0 ), and two hydroxy-myristic acid groups (3-OH-C 14:0 ). 7, 8 The data acquired for the unlabeled [ 12 C]-lipid A sample ( Fig. 1 , Table 1 ) agreed with this previously described structure. The monophosphorylated lipid A (MPLA) peaks for the 12 C, 13 CEO, and 13 CE samples were observed at m/z 1632.1, 1670.1, and 1708.4, respectively (Fig. 1, Table 1 ). The mass differences observed for the [ 12 C]-MPLA peak compared to the [ 13 C]-MPLA peaks were increases of 38
Stable isotope metabolic labeling of Neisseria meningitidis lipooligosaccharide 95 13 CE samples, respectively ( Fig. 1 , Table 1 ). As observed in the MPLA species, the mass of 13 CE-DPLA was 76 Da higher than the mass of 12 C-DPLA. The peaks observed at m/z 1433.9, 1466.0, and 1498.2 likely originate from partial hydrolysis of the Since the MPLA species were observed in all of the samples, the isotopic distribution observed from these samples was used to determine the percentage incorporation of the [ 13 C]-metabolic label. Figure 2 shows the MPLA species observed from all three samples. The percentage incorporation of the [ 13 C]-metabolic label was determined with the Isotope Pattern Calculator 1.6.6 (Les Arnold). This program determined that the 13 CEO sample and the 13 CE sample had incorporation efficiencies of about 97.3% and 98%, respectively. The insets in Figure 2B ,C are graphs based on the relative intensities determined from the Isotope Pattern Calculator. The inset in Figure 2A is a graph based on the actual intensities of the isotopes measured.
The LOS structure for the NMBACE1 parent strain, N. meningitidis strain NMB, has been characterized 8, 22 and is shown in Figure 3 . To determine the positions of [ 13 C]-incorporation into the oligosaccharide portion of these LOSs, the molecular ions of the full-length oligosaccharides, based on this structure, were identified and selected for collision-induced dissociation. The tandem spectra obtained from the fragmentation of the doubly charged molecular ions corresponding to an oligosaccharide with a composition of Hex 4 , HexNAc 2 , Hep 2 , anhydroKdo are shown in Figure 4 . The precursor ions, shown in bold in each spectrum, were observed at m/z 830.3 2+ , 831.3 2+ , and 832.3 2+ (corresponding to M obs = 1658.5, 1660.6, and 1662.6) for the 12 C, 13 CEO, 13 CE OS samples, respectively. These data demonstrate that the overall mass differences between the [ 12 C]-samples compared to the [ 13 C]-samples were 2 Da ( 13 CEO) and 4 Da ( 13 CE). The proposed structures for the fragment ions are indicated in Figure 4 and in Table 2 . The fragment ions at m/z 204.1, 205.1, and 206.1, correspond to one nonreducing terminal GlcNAc from 12 C, 13 CEO, and 13 CE, respectively. These data clearly show that one ( 13 CEO) or two ( 13 CE) labeled carbons are incorporated into this Nacetylated amino sugar. The additional fragment ions listed in Table 2 demonstrate that when one GlcNAc residue is present, there is a difference of either 1 Da ( 13 CEO) or 2 Da ( 13 CE) compared to the [ 12 C]-sample; when two GlcNAc residues are present, there is either a difference of 2 Da ( 13 CEO) or 4 Da ( 13 CE) compared to the [ 12 C]-sample. These data demonstrate that either one ( 13 CEO) or two ( 13 CE) carbons are labeled in each of the GlcNAc residues present on the OS structure. Since the NMBACE1 strain is blocked in its ability to generate acetate from pyruvate, the incorporation of the [ 13 C]-label into the GlcNAc residues most likely occurs through the transfer of a labeled acetyl group from acetyl-CoA to glucosamine-1-phosphate. These findings suggest that the biosynthesis of UDP-GlcNAc by N. meningitidis is similar to that of Escherichia coli. 23, 24 In this study, we demonstrated that we could metabolically incorporate [ 13 C]-labeled acetate into the GlcNAc Stable isotope metabolic labeling of Neisseria meningitidis lipooligosaccharide 97 sugars of the oligosaccharide and into the acyl chain substitutions of the lipid A. This labeling strategy was straightforward, highly efficient, and specific. This labeling strategy has a number of advantages over using the previously described [ 14 C]-labeling of LOS. 20 Among these advantages is that [ 13 C]-labeled LOS is useful in quantitative mass spectrometry studies due to its stable nature, while [ 14 C]-LOS is not useful for these types of studies. Additionally, [ 13 C]-labeled LOS is amenable to NMR analysis, while [ 14 C]-labeled LOS is not. The high incorporation of the [ 13 C]-label into the LOS will increase its signal for 13 C-NMR experiments. This increase in signal for NMR experiments would be especially evident with the LOS labeled with the sodium [1,2-13 C 2 ]-acetate. This strong signal will offer not only easier data acquisition, and the ability to work with smaller quantities of LOS, but will also provide specificity as to the location of specific LOS components (GlcNAc and lipid A acyl chains). Moreover, this [ 13 C]metabolic LOS labeling strategy should now enable structural studies focused on the interactions between LOS and host innate immune system proteins, such as LBP, CD14 and MD-2.
